Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Dr Reddy’s Gears For Sputnik Pediatric Shot, Molnupiravir Upside

Nov 01 2021

• By Anju Ghangurde

sputnik — Dr Reddy's Primes Life Cycle Management Plans For Sputnik • Source: Alamy

Related Content

Merck’s Molnupiravir Open License With Medicines Patent Pool May Be Model

Oct 28 2021

Dr Reddy’s Gears For Sputnik Light In India, Jab For Adolescents

Jul 29 2021

Zydus Cadila Turns DNA Pioneer With COVID-19 Vaccine Approval

Aug 24 2021

Merck Forecasts Global Molnupiravir Revenues Of $5bn-$7bn Through 2022

Oct 28 2021

Pediatric COVID-19 Vaccine Face-Off Looms As Bharat Biotech Heads For Approval

Oct 14 2021

Deciphering Molnupiravir’s India Trial Discontinuation In Moderate COVID-19

Oct 13 2021

Molnupiravir India Licenses: Nuances, Local Data In Focus

Apr 28 2021

Sputnik V Cleared in India, Trajectory Against Variants May Be Key

Apr 14 2021

Related Companies

Dr. Reddy's Laboratories Ltd.

Zydus Lifesciences Limited

Bharat Biotech

Pfizer Inc.

BioNTech SE

AstraZeneca PLC

Serum Institute of India Pvt. Ltd.

University of Oxford

Gland Pharma Limited

Hetero Drugs Ltd.

Panacea Biotec Ltd.

Merck & Co., Inc.

Ridgeback Biotherapeutics LP

Aurobindo Pharma Limited

Additional Topics

India Asia Pacific Commercial Coronavirus COVID-19 Vaccines BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window